NCT05806788

Brief Summary

Twenty women, ages 60 or older, will be consented and enrolled in a single-arm, pilot implementation trial of the age-tailored cognitive-behavioral based BE intervention. Participants will complete assessments at baseline, post-intervention, and at two follow-up timepoints; weekly BE frequency will be collected to monitor progress during the intervention period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 17, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 22, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

April 10, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 14, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 14, 2023

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

January 7, 2025

Completed
Last Updated

January 7, 2025

Status Verified

December 1, 2024

Enrollment Period

9 months

First QC Date

March 22, 2023

Results QC Date

November 11, 2024

Last Update Submit

December 18, 2024

Conditions

Keywords

Binge Eating SpectrumCognitive-behavioral therapyBody Image

Outcome Measures

Primary Outcomes (2)

  • Feasibility - Usage Rating Profile - Intervention

    Score on the Feasibility Usage Rating Profile. This scale gathers patient reported feasibility of the intervention (e.g., time needed, quality of materials, simplicity of the intervention) to be completed after doing the intervention. This scale has six items; total scores range from 1-6 and a higher scores indicate greater feasibility.

    6 weeks (post), and 2 month follow-up

  • Acceptability - Usage Rating Profile - Intervention

    Score on the Acceptability Usage Rating Profile scale which gathers participant ratings of how acceptable the treatment is for targeting binge eating (e.g., how helpful the intervention was, how much they liked it, willingness to do the intervention) to be completed after doing the intervention. This scale has eight items; total scores range from 1-6, a higher score indicates greater acceptability.

    6 weeks (post), and 2 month follow-up

Secondary Outcomes (2)

  • Binge Eating Score (BES)

    Baseline, 6 weeks, 1 month, and 2 month follow-up

  • Geriatric Depression Scale Score (Center for Epidemiologic Studies-Depression Scale; CES-D)

    Baseline, 6 weeks (post), 1 month, and 2 month follow-up

Study Arms (1)

BESTOW behavioral intervention

EXPERIMENTAL

The intervention will utilize behavioral-based strategies to reduce BE and improve health behaviors, with content including strategies to improve body image, regulation of eating behaviors, and integration of physical activity with an emphasis on body function, health, and longevity.

Behavioral: Binge Eating Syndrome Treatment (BESTOW)

Interventions

The BESTOW program involves discussions as well as written and behavioral activities. Participants will also be asked to complete activities, or 'homework,' in between sessions that will help to stop binge eating and to improve eating habits.

BESTOW behavioral intervention

Eligibility Criteria

Age60 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women
  • Age 60 years and over
  • Binge eating (BE) ≥1/week during the past ≥3 months
  • Community-dwelling
  • Able to provide informed consent
  • Consistent medication regimen for 3 months

You may not qualify if:

  • Significant cognitive impairment
  • Nursing home, long-term care facility
  • Psychosis or imminent suicide risk
  • Current BE treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas Health Science Center at San Antonio

San Antonio, Texas, 78253, United States

Location

MeSH Terms

Conditions

Bulimia

Condition Hierarchy (Ancestors)

HyperphagiaSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Lisa Smith Kilpela
Organization
UT Health San Antonio

Study Officials

  • Lisa Kilpela, PhD

    University of Texas Health Science Center San Antonio

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: This study is a beta-testing of a new behavioral intervention treatment - all participants will be assigned to the treatment and give feedback on the treatment throughout the study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 22, 2023

First Posted

April 10, 2023

Study Start

February 17, 2023

Primary Completion

November 14, 2023

Study Completion

November 14, 2023

Last Updated

January 7, 2025

Results First Posted

January 7, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

Per guidelines, we will publish deidentified data results from this trial via ClinicalTrials.gov within one year of study completion. Participants will be informed of this at the time of consent, if they are interested in learning the results from the study.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Within one year of study completion

Locations